The Canadian Institutes of Health Research (CIHR) is seeking members for its new Standing Committee on Science. The committee will have a diverse membership made up of nationally and internationally […]

Members in action Did you know? ASBMR Osteoporosis Canada will be releasing updated Osteoporosis Management Clinical Guidelines in the fall of 2019. Along with a steering committee, working groups have […]

THE CMC 2023 COMMITTEE  CHAIR: Dr. Rowena RidoutVice Chair: Dr. Claudia Gagnon SCIENTIFIC COMMITTEE MEMBERS Dr. Rowena Ridout Dr. Claudia Gagnon Dr. Heather McDonald Blumer Dr. Heather Frame Dr. Sandra […]

Latest News IOF Welcomes Dr. Famida Jiwa as Chair of the Committee of National Societies February 9, 2024 Following the elections held for the position of Chair of the International […]

Osteoporosis Canada is pleased to share that long-time volunteer Dr. Hilary Jaeger is one of three leaders recognized as Honorary Fellows of the Royal College for her transformative contributions to […]

Board of Directors Jeannette Briggs Chair | Oakville, ON Jeannette has more than 25 years of experience working in the energy sector.  She has held a wide-range of jobs within […]

We are aware of a recent Food and Drug Administration (FDA) publication that reports on the association between use of zoledronic acid (Aclasta) and renal impairment. 1 We recognize that […]

We are aware of a recent Food and Drug Administration (FDA) publication that reports on the association between use of zoledronic acid (Aclasta) and renal impairment. 1 We recognize that […]

We are aware of recent press reports concerning the link between two drugs for osteoporosis (alendronate and zoledronate) and the occurrence of a heart condition characterized by an irregular heart […]